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Background   A number of excellent results with the cement-
less titanium femoral component of the Mallory Head Total Hip 
Replacement have been published. Unfortunately, these excellent 
results have been counteracted by the poor performance of the 
cementless titanium acetabular components. In 1994, the HexLoc 
acetabular component was replaced with a second-generation 
design, the RingLoc. We hypothesized that the new generation 
would have improved the results. 
Methods   We retrospectively studied 111 consecutive patients 
(150 hips) younger than 55 years. Median follow-up time was 14 
(6–18) years for the HexLoc and 10 (1–14) years for the RingLoc. 
7 patients were lost to follow-up and 7 patients died. The 10-year 
survival rate, radiographic liner wear, and radiographic signs of 
prosthesis failure were compared between the 2 acetabular com-
ponents. 
Results   The Kaplan-Meier survival estimate with revision for 
any reason as the endpoint showed a 10-year survival of 89% 
(95% CI: 81–97) for the HexLoc and 92% (CI: 85–98) for the 
RingLoc. The mean annual wear rate for the HexLoc was 0.16 
(SD 0.16) mm and it was 0.15 (0.1) mm for the RingLoc (p = 
0.3). The radiographic signs of failure were equally distributed 
between the 2 groups.
Interpretation   Compared to the HexLoc type, the RingLoc 
system did not improve the mean percentage survival at 10 years; 
nor did it reduce the liner wear. Despite correction of the known 
design flaws in the HexLoc design, the RingLoc system did not 
show a clinically relevant improvement compared to its predeces-
sor.

Tapered designs for cementless femoral components have 
shown excellent clinical and radiographic results. Numerous 
authors have reported that these stem designs provide reliable 
fixation in the long term (Rothman et al. 1996, Hellman et al. 
1999, Sakalkale et al. 1999, Mallory et al. 2001, Meding et al. 
2004). In addition, these tapered cementless femoral designs 
have also been shown to give outstanding results in younger 
patients (Ellison et al. 2006).
Unfortunately, the results with cementless acetabular com-
ponents do not match the success with their femoral coun-
terparts (Bourne et al. 2001). High rates of wear have been 
reported, which can cause periprosthetic osteolysis (Harris 
2004) and subsequent loosening of the component. 
One of the components associated with inferior results is the 
cementless acetabular cup with a HexLoc liner (Biomet Inc., 
Warsaw, IN) locking system (Hozack et al. 1996, Puolakka et 
al. 1999). The HexLoc system was withdrawn from the market 
in 1994 and replaced by a new acetabular cup design with a 
RingLoc liner locking system (also Biomet).
We hypothesized that the new acetabular cup combined 
with the RingLoc liner locking system would have improved 
the 10-year survival in younger patients as compared to the 
former acetabular cup with the HexLoc liner locking system. 
Secondly, we hypothesized that the new cup would show less 
linear wear and would have reduced the number of radio-
graphic failures.
Patients and methods
Patients (Table 1)
We conducted a retrospective cohort study on all consecu-
tive cementless total hip prostheses (Mallory Head; Biomet 
Inc.) in patients younger than 55 years at the index opera-
tion, all inserted at the Leiden University Medical Center 
between 1990 and 2000. 111 consecutive patients (150 hips) 
were included. At final follow-up in 2008, 7 patients were lost 
to follow-up. 6 of them were living outside the Netherlands 
and 1 patient could not be traced. 7 patients (12 hips) died 
during the study period for causes unrelated to their hip sur-Acta Orthopaedica 2011; 82 (6): 664–668  665
gery. 1 of these patients (1 hip) had been revised before death. 
All deceased patients were included in the survival analysis. 
This left 104 patients (141 hips) with a median follow-up of 
12 (1–18) years for review. The patients were divided into 
2 groups based on the acetabular component that was used, 
HexLoc (the H group) or RingLoc (the R group).
Median follow-up for the H group was 14 (6–18) years, and 
for the R group it was 10 (1–14) years. Previous resurfacing 
hip surgery had been performed in 19 hips in group H, includ-
ing 17 Gerard double-cup arthroplasties (Duijsens et al. 2005) 
and 2 Thomine cups (a monopolar design). In group R, only 
8 hips had had a previous operation, 4 Gerard double-cup 
arthroplasties, 3 Thomine fitted cups, and 1 Aufranc Smith-
Peterson cup. 
Surgery
A direct lateral hip approach was used in all patients. In 13 
cups in group H and in 9 cups in group R, screws were used 
for additional stability of the acetabular components. Addi-
tional screws were used based on the surgeon’s perception of 
initial stability of the acetabular component during surgery. 
Indications for revision surgery were similar in both groups; 
in both groups revision was planned for end-stage liner wear 
or radiographic loosening of the acetabular component. None 
of the femoral stems had to be revised during the follow-up 
period.
Implants
The Mallory Head porous coated femoral stem made of 
Ti6Al4V (Biomet) was used in all of the hips, combined with 
a 28-mm CoCr head in all cases but 2, where a ceramic head 
was used. 
The Mallory Head (Biomet, Warsaw, IN) porous coated 
acetabular cup was used—combined with the HexLoc liner 
locking system in all cases—until it was withdrawn from the 
market in 1994. It was replaced with the RingLoc system, 
which was then used at our center. All cups had holes for 
screw fixation. The older cups combined with the HexLoc had 
12 screw holes whereas the second generation has 7 holes for 
additional screw fixation of the cup with respect to the bone. 
The HexLoc system had a cylindrical shape at the inside of 
the acetabular metal shell, which caused the liner to be asym-
metric and thinner at the edges (Hozack et al. 1996). The 
RingLoc acetabular cup does not have this liner incongruence 
at the edge. The size distribution of acetabular components 
was similar in both groups, the median being 52 (45–70) mm 
(Mann-Whitney U test; p = 0.2). The bearing materials used in 
both groups were ArCom liners made from 1900H ultra-high 
molecular weight polyethylene resin. 
Clinical evaluation
For evaluation, demographic data, previous surgery, radio-
graphic variables, and clinical scores were collected from the 
medical records. All patients were assessed within 2 years of 
the study date to ensure recent data, either as part of their rou-
tine follow-up or at an extra follow-up for the current study. 
A prospective Harris hip score was taken preoperatively. At 
the last follow-up, a final Harris hip score was obtained for 
measurement of patient outcome. 
Radiographic evaluation
All radiographs were assessed by one observer who was 
blinded regarding all patient-related information. Antero-
posterior (AP) non-weight bearing pelvic and femoral digi-
tal radiographs were taken at the last follow-up visit. These 
radiographs were compared to the radiographs taken imme-
diately postoperatively. Radiographs were evaluated for signs 
of periprosthetic radiolucent lines, cortical hypertrophy, and 
bone resorption. The inclination of the acetabular cup was 
measured by drawing a horizontal line through the inferior 
edge of the teardrops and a second line through the superior 
and inferior edge of the acetabular cup (Wan et al. 2008). The 
angle between these 2 lines was measured.
Linear wear was measured as described by Dorr and Wan 
(1995) and Ebramzadeh et al. (2003). Periacetabular radiolu-
cencies and osteolysis were assessed according to DeLee and 
Charnley (1976). The annual wear was calculated by dividing 
the total wear by the total follow-up time in years. 
The cup was considered radiographically loose if a radiolu-
cent line was wider than 2 mm and extended along all 3 zones 
of the acetabular component (Mann et al. 2002).
Statistics
Survivorship analysis was done according to Kaplan and 
Meier. Survival estimates were deemed sufficiently accurate 
when at least 15 hips were still at risk (Dorey 2004). A log 
rank test was used to test for the difference in mean survival 
time between the 2 groups. To account for bilateral hips, we 
performed the survival analysis twice: including the 2 hips and 
Table 1. Baseline characteristics of the 2 groups
   HexLoc  RingLoc
Total number of hips  64  77
Males/females  23/41 32/45
Mean age at surgery  41 (17–55)  42 (15–55)
Previous hip surgery  19    8
Mean preoperative HHS  43 (14–73)  43 (4–74)
Average BMI  24  24
Additional screw fixation  11    9
Deceased    5    6
Etiology  
  Rheumatoid arthritis  23   24
  Ankylosing spondylitis  10     9
  Femoral head necrosis    9   16
  Primary osteoartritis    7    9
  Hip dysplasia/luxation    6    8
  Trauma    1    3
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randomly including 1 of the 2 hips. The difference in risk was 
calculated using the number of events (revisions) and persons 
at risk 10 years after the index operation.
Differences between variables with a normal distribution, 
including the annual wear rate, were tested using a linear 
mixed models analysis. This test is essentially a t-test, taking 
into account the bilateral hips.
All statistical analyses were performed using SPSS version 
14.0. Statistical significance was assumed with p-values of 
< 0.05.
Results
Revisions
No femoral stems were revised, giving a mean 16-year survival 
of 100% with 16 hips at risk. During follow-up, 33 acetabular 
components were revised, either for liner wear or for acetabu-
lar loosening, or both. 25 revisions (22 liner exchanges, 3 cup 
revisions) were performed in the H group, as opposed to 8 (5 
liner exchanges, 3 cup revisions) in the R group. 
The subgroup analysis showed that at final follow-up, 28 
of the 114 hips with no prior hip resurfacing were revised: 22 
of them were liner revisions and 6 were cup revisions. In the 
resurfacing group, 6 of 27 hips had a liner revision and none 
of the metal-backed cups had to be revised. 
Survival analysis
The 10-year survivorship in group H was 89% (95% CI: 
81–97) with 55 cases at risk, and it was 92% (CI: 85–98) with 
41 cases at risk in group R (Table 2). The observed difference 
of 3% in 10 years was not statistically significant (p = 0.5). 
Also, there was no significant difference when we randomly 
excluded one of the bilateral hips (p = 0.2).
The Kaplan-Meier survival curves for the 2 groups were 
similar up to 12 years of follow-up (Figure 1). After 12 years, 
an insufficient number in group B were at risk. The difference 
in risk between the 2 groups at 10 years was 0.005 (CI: –0.13 
to 0.14). The subgroup analysis showed a slightly higher 
10-year survival for the resurfacing group—91% (CI: 79–100) 
vs. 90% (CI: 84–96)—but the difference was not statistically 
significant (p = 0.4). The 10-year survival for patients with 
rheumatoid arthritis was higher—at 93% (CI: 86–100) vs. 
88% (CI: 81–96)—but the difference was also not significant. 
(p = 0.3). 
Liner wear
Mean annual liner wear in group H was 0.16 (CI: 0.12–0.20; 
range: 0.00–1.13) mm/year. Group R showed a similar wear 
rate of 0.15 (CI: 0.13–0.17; range: –0.01 to 0.41) mm/year 
(p = 0.7).
A small effect of a previous resurfacing arthroplasty was 
seen on liner wear. In this subgroup, the mean liner wear was 
slightly higher at 0.18 (CI: 0.12–0.25) mm/year, as opposed 
to 0.15 (CI: 0.12–0.18) mm/year for those with no previous 
resurfacing, but this was not significant (p = 0.3). 
A moderate effect of rheumatoid arthritis was seen on the 
annual wear. In this subgroup, it was slightly lower at 0.12 
(CI: 0.07–0.17) mm/year, as opposed to 0.17 (CI: 0.14–0.21) 
mm/year in those with no rheumatoid arthritis, but this did not 
reach statistical significance (p = 0.08).
Radiographic results
The mean postoperative cup inclination was 46 (30–72) 
degrees in the HexLoc group and 45 (26–61) degrees in the 
RingLoc group.
In the 3 zones around the acetabular component, progressive 
radiolucent lines were seen in 25% of the cups. Most radio-
lucent lines were located in zone 2 (Figures 2 and 3), with 
group H showing more lines in zone 2 than group R (43% vs. 
27%). 3 cups (3%), 1 in group H and 2 in group R, showed 
progressive radiolucent lines of more than 3 mm in all 3 zones, 
indicating a radiographically loosened cup.
Clinical results
The mean preoperative Harris hip score was 43 (SD 15) and 
the mean postoperative score at final follow-up was 83 (SD 
19).
Table 2. Survival estimates for the 2 groups (95% CI)
Survival (years)  HexLoc  At risk  RingLoc  At risk
  5  100%  63  100%  69
10    89% (81–89)  55    92% (85–99)  41
12    77% (67–87)  47    86% (77–96)  15
16    49% (34–63)  16
 
Figure 1. Kaplan-Meier survival curve. Blue: HexLoc; green: RingLoc.Acta Orthopaedica 2011; 82 (6): 664–668  667
Discussion
The newer, second-generation Mallory Head acetabular cup 
did not have a higher mean survival time than the first-gener-
ation cups in patients younger than 55 years. Also, we did not 
find any improvement in linear wear rates, number of radio-
graphic failures, or clinical outcome.
Our survival analysis suggests that the RingLoc system 
is not an improvement over the HexLoc system. No statisti-
cally significant difference in mean survival time between the 
groups could be found. The log rank test indicated that there 
were no differences between the 2 groups, and the difference 
in risk was close to 0 (0.5%) with a fairly narrow confidence 
interval (–13 to 14%), indicating that no clinically significant 
improvement had been made (Nelissen et al. 1992). 
A possible explanation for the poor reported survival of 
the HexLoc system is the cylindrical shape of the acetabular 
cup, which causes the liner to be asymmetric and thinner at 
the edges (Hozack et al. 1996). However, the newly designed 
acetabular cup with the RingLoc system does not have this 
liner incongruence. No obvious design flaws are apparent in 
the RingLoc design.
Comparison of cementless acetabular component survival 
in the literature shows good mean survival rates at 5 years, 
with declining values after this medium-term result Eskelinen 
et al. (2006). The same is true of both acetabular components 
studied here. Unfortunately, only a few cementless cups have 
well-documented 10-year survival. Eskelinen et al. (2006) 
reported results of different cementless cups in young patients 
with the survival at 10 years varying between 71% and 87%. 
The mean survival times of 89% and 92% at 10 years reported 
here suggest that this design does perform reasonably well in 
our cohort of young patients—as compared to other designs—
at 10 years. Only 1 report, from the Finnish Arthroplasty Reg-
ister (Eskelinen et al. 2006), gave 10-year survival of the Mal-
lory Head cup with a HexLoc system. The authors reported a 
10-year survival of 61% with revision for any reason as the 
endpoint. Our reported 10-year survival of the HexLoc system 
of 89% is substantially higher. One explanation could be that 
the distribution of preoperative diagnoses (Helse-Bergen HF, 
2007)—with a relatively large group of patients with multiple 
lower extremity joint involvement in our study (e.g. rheuma-
toid arthritis)—can lead to a less active group of patients. This 
less active group would be more likely to have less liner wear, 
and subsequently less prosthetic loosening and lower revision 
rates. Our subanalysis showed a slightly lower annual liner 
wear rate (0.12 mm/year vs. 0.17 mm/year) for patients with 
rheumatoid arthritis, which supports this hypothesis. The 
higher prevalence of rheumatoid arthritis patients was due to 
tertiary referral to our university medical center.
The annual liner wear reported in the literature ranges from 
0.11 mm/year (Yamamoto et al. 2003) to 0.14 mm/year (Puo-
lakka et al. 2001) for 28-mm heads. This is slightly less than 
in our group, but unexpectedly, this did not result in a lower 
mean survival at 10 years. Comparing the 2 generations of 
acetabular components, the wear analysis showed an equal 
amount of wear in both groups, suggesting that the increased 
thickness of the liner at the acetabular metal shell edge had no 
effect on the wear rate measured. Thus, thinning at the edge 
of the polyethylene liner,  due to the cup-liner incongruence in 
the HexLoc design, may not be an important issue. 
No fair comparison of radiographic changes, except annual 
wear rate, between the 2 generations of acetabular component 
could be made at the last follow-up. This is due to the fact 
that the H group had a longer mean follow-up time, and thus a 
longer exposure time to wear, than the R group. 
A possible source of bias in this study was that both groups 
included patients who had had previous hip resurfacing 
arthroplasty. The reason that these patients were included is 
that they had only had cementless resurfacing hip surgery 
and not a conventional total hip arthroplasty. Although revi-
sion surgery in general suggests a higher re-revison rate, in 
this “revision” group, none of the metal-backed acetabular 
components had to be revised and only 6 liner revisions had 
to be performed. The 10-year survival for these patients was 
even slightly better than for those with no previous resurfacing 
(91% vs. 90%), but this was not statistically significant. None 
of these metal-backed components had to be revised, and the 
Figure 2. Radiolucencies around the acetabulum in the HexLoc group. Figure 3. Radiolucencies around the acetabulum in the RingLoc group.668  Acta Orthopaedica 2011; 82 (6): 664–668
10-year survival was comparable, which suggests that in our 
study these hip resurfacings did not have any negative influ-
ence on the results. 
Our findings confirm that the Mallory Head porous coated 
femoral component gives excellent results in young patients. 
Furthermore, in contrast to the alarming reports in the liter-
ature (Hozack et al. 1996, Puolakka et al. 1999, 2001), our 
results suggest that the Mallory Head cementless acetabular 
components are a reasonable choice for young patients. They 
also indicate that the RingLoc system does not provide any 
clinically relevant improvement over the moderate results of 
the older Hexloc system, despite the correction of the potential 
design flaws.
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